-
Federal
COVID-19 Hospital Data Coverage Report
U.S. Department of Health & Human Services —
After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and... -
Federal
Respiratory Virus Response (RVR) United States Hospitalization Metrics by Jurisdiction, Timeseries
U.S. Department of Health & Human Services —
Note: After May 3, 2024, this dataset will no longer be updated because hospitals are no longer required to report data on COVID-19 and influenza hospital admissions,... -
Federal
Workers' compensation claims related to natural rubber latex gloves among Oregon healthcare employees from 1987–1998
U.S. Department of Health & Human Services —
Background Occupational reaction to natural rubber latex (NRL) glove use by healthcare employees has been an area of increasing concern. Unfortunately, there is... -
Federal
Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
U.S. Department of Health & Human Services —
Background Mefloquine is a clinically important antimalaria drug, which is often not well tolerated. We critically reviewed 516 published case reports of mefloquine...